СУЧАСНІ СТАН ПРОБЛЕМИ НЕФРОПРОТЕКТОРНОЇ ТЕРАПІЇ ПРИ ДОБРОЯКІСНІЙ ГІПЕРПЛАЗІЇ ПЕРЕДМІХУРОВОЇ ЗАЛОЗИ

Автор(и)

  • O. S. Fedoruk
  • V. V. Viznyuk

DOI:

https://doi.org/10.24061/1727-0847.10.1.2011.18

Ключові слова:

доброякісна гіперплазія передміхурової залози, нефропротекторна терапія, ниркова недостатність

Анотація

Наведені дані вітчизняних та зарубіжних авторів про нефропротекторну терапію у перед- та післяопераційному періодах лікування доброякісної гіперплазії передміхурової залози. Установлено клінічно-патогенетичні особливості розвитку ниркової недостатності у даної категорії хворих.

Посилання

Hamm RS, MacDermott SM. Renal function in men with lower urinary tract symptoms at first presentation to urology out-patient department. Ann. R. Coll. Surg. Engl. 2004;86(3):182-5.

Walsh PC, Retnik AB, Vaughan ED. Pathophysiology of urinary tract obstruction. Campbell's Urology. 7-th ed. Philadelphia: W.B.Saunders Company; 1998. p. 343-60.

Saidakova NO, Startseva LM, VV.Kuznietsov VV, Hrytsai VS. Dobroiakisna hiperplaziia peredmikhurovoi zalozy u strukturi hospitalizovanoi zakhvoriuvanosti ta operatyvnykh vtruchan' [Benign prostatic hyperplasia in the structure of hospitalized morbidity and surgical interventions]. Zdorov'e muzhchynы. 2009;1:172-8. (in Ukrainian).

Vertkin AL, Rodyukova IS, Galkin IV, Arinina EN. Ne prosto prostata: problemy dobrokachestvennoy giperplazii predstatel'noy zhelezy u pozhilykh [Not just the prostate: the problems of benign prostatic hyperplasia in the elderly]. Farmateka. 2009;9:50-5. (in Russian).

Shcherbak AYu, Kravchenko NI, Vilivok NN. Optimizatsiya taktiki lecheniya bol'nykh posle operatsii na predstatel'noy zheleze [Optimization of the tactics of treatment of patients after surgery on the prostate gland]. Bukovinian Medical Herald. 2008;12(4):10-3. (in Russian).

Hellstrom W, Smith W, Sikka C. Effects of alpha-blockers on ejaculatory function in normal subjects. Program and abstracts of the American Urological Association Annual Meeting; may 21-26, 2005. San Antonio: Texas; 2005. Abstract 874.

Munterner M, Aellig S, Kuttel R. Perioperative morbidity and changes in symptom scores after transurethral prostatectomy in Switzerland: results of an independent assessment of outcome. BJU Int. 2006;98(3):381-3.

Sutaria PM, Staskin DR. Hydronephrosis and renal deterioration in the elderly due to abnormalities of the lower urinary tract and ureterovesical function. Int. Urol. and Neph. 2000;32(1):119-26.

Zorkin SN, Khvorostov IN, Borisova SA, Gusarova TN, Dvoryakovskiy IV, Skutina LE. Vozmozhnosti renoprotektornoy terapii u bol'nykh s obstruktivnymi uropatiyami [The possibilities of renoprotective therapy in patients with obstructive uropathies]. Pediatriya. 2007;86(6):24-8. (in Russian).

Khvorostov YN, Zorkyn SN, Smyrnov YE. Obstruktyvnaia uropatyia [Obstructive uropathy]. Urology. 2005;4:73-7. (in Russian).

Vozianov OF, Fedoruk OS, Hozhenko AI. Hostra nyrkova nedostatnist' [Acute renal failure]. Odesa: ODMU; 2003. 376 p. (in Ukrainian).

Katerenchuk IP, Pustovoit AL. Adaptyvne remodeliuvannia strukturnykh komponentiv nyrkovoi ktanyny z vikom [Adaptive remodeling of structural components of renal ktani with age]. World of Medicine and Biology 2008;3:58-62. (in Ukrainian).

Vladychenko KA. Dobroiakisna hiperplaziia prostaty ta renal'na dysfunktsiia [Benign prostatic hyperplasia and renal dysfunction]. Bukovinsan Medical Herald. 2008;12(2):20-5. (in Ukrainian).

Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade R, et al. The relationship between lower urinary tract symptoms and health status: the UREPIK study. BJU Int. 2003;92(6):575-80.

Fedoruk OS, Vladychenko KA. Perebih renal'noi dysfunktsii pry operatyvnomu likuvanni dobroiakisnoi hiperplazii prostaty [The course of renal dysfunction during operative treatment of benign prostatic hyperplasia]. In: Proceedings of the mezhdunarodnoi nauchno-praktycheskoi konferentsyy. Sovremennыe napravlenyia teoryy y prykladnыkh yssledovanyi; 2008 March 15-25; Odessa: The Black Sea Coast; 2008;21:67-9. (in Ukrainian).

Denton KM, Shweta A, Flower RL, Anderson WP. Predominant postglomerular vascular resistance response to reflex renal sympathetic nerve activation during ANG II clamp in rabbits. Am. J. Physiol.Regul. Integr. Comp. Physiol. 2004;287(1):780-6.

Miyajima A, Chen J, Poppas DP. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int. 2001;59(4):1290-1303.

Annuk M, Sovori I, Zilmer M, Lind L, Hulthe J, Fellstrom B. Endothelial function CRP and oxidative stress in chronic kidney disease. J. Nephrol. 2005;18(6):721-6.

Plesh IA, Boreiko LD, Haidukov VA, Troian AM, Suk TI. Tsyrkadiannyi rytm arterial'noho tysku, funktsional'na aktyvnist' sertsia ta nyrok u likuvanni khvorykh na esentsial'nu hipertenziiu [Circadian rhythm of arterial pressure, functional activity of the heart and kidneys in the treatment of patients with essential hypertension]. Bukovinsan Medical Herald. 2010;14(3):59-66. (in Ukrainian).

Slobods'kyi VA. Dosvid zastosuvannia preparatu Tyvortyn aspartat pry likuvanni patsiientiv zi stabil'noiu stenokardiieiu napruzhennia [Experience with Tivortin aspartate in the treatment of patients with stable angina pectoris]. Ukrains'kyi medychnyi chasopys. 2009;5:40-3. (in Ukrainian).

Horoshko OM, Zamors'kyi II, Herush OV. Nefroprotektorni vlastyvosti preparativ kvertsetynu (korvityn ta lipoflavon) na modeli hentamitsynovoi nefropatii [Nephroprotective properties of quercetin preparations (corvitin and lipoflavone) on the model of gentamicin nephropathy]. Clinical and Experimental Patholigy. 2009;8(3):19-22. (in Ukrainian).

Mokhort MA, Danova IV, Myslyvets' SO. Farmakodynamika kvertsetynu ta yoho likars'kykh form [Pharmacodynamics of quercetin and its pharmaceutical forms]. Pharmacology and Drug Toxicology. 2009;13(6):3-7. (in Ukrainian).

Kharchenko VV. Osnovni mekhanizmy dii liposomal'noho kvertsetynu v likuvanni khvorykh na nealkohol'nu zhyrovu khvorobu pechinky v poiednanni z hipertonichnoiu khvoroboiu [The main mechanisms of action of liposomal quercetin in the treatment of patients with non-alcoholic fatty liver disease in combination with hypertension]. Fitoterapiia. 2009;2:14-6. (in Ukrainian).

Vladychenko KA. Vplyv hlutarhinu na stan prota antyoksydantnoi system krovi pry operatyvnomu likuvanni dobroiakisnoi hiperplazii prostaty [Effect of glutargin on the state of antioxidant blood systems in operative treatment of benign prostatic hyperplasia]. Clinical and Experimental Patholigy. 2008;7(2):18-23. (in Ukrainian).

Horoshko OM, Haras MN. Vplyv antyoksydantnykh vlastyvostei korvitynu na perebih hostroi eksperymental'noi nyrkovoi nedostatnosti [Influence of anti-oxidant properties of corvethan on the course of acute experimental renal failure]. Bukovinsan Medical Herald. 2007;11(3):119-22. (in Ukrainian).

Fedoruk OS, Vladychenko KA, Kyfiak PV. Zminy elektrolitnoho balansu pry operatyvnomu likuvanni dobroiakisnoi hiperplazii prostaty [Changes in electrolyte balance in surgical treatment of benign prostatic hyperplasia]. In: Proceedings of the IV mizhnarodnoi naukovo-praktychnoi konferentsii. Dynamika naukovykh doslidzhen' – 2005; 2005 Jun 20-30; Dnipropetrovsk: Nauka i osvita; 2005. Vol. 29 p. 11-2. (in Ukrainian).

Starkman JS, Santucci RA. Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: shorter stay, earlier catheter removal and fewer complications. BJU Int. 2005;95(3):69-71.

Chen SS, Lin AT, Chen KK. Hemolysis in transurethral resection of the prostate using distilled water as the irrigant. J. Chin. Med. Assoc. 2006;69(6):270-5.

Vozianov OF. Rekomendatsii Yevropeis'koi asotsiatsii urolohiv [Recommendations of the European Association of Urologists]. Kiev; 2006. 120 p. (in Ukrainian).

Dziurak VS, Babynin DA. Suchasnyi pidkhid do diahnostyky ta terapii dobroiakisnoi hiperplazii peredmikhurovoi zalozy [Modern Approach to Diagnosis and Therapy for benign prostatic hyperplasia]. Liky Ukrainy. 2005;2:111-2. (in Ukrainian).

Borisov VV. Medikamentoznaya terapiya i kachestvo zhizni bol'nykh giperplaziey prostaty [Drug therapy and quality of life of patients with prostatic hyperplasia]. Vrachebnoe soslovie. 2007;2:4-8. (in Russian).

##submission.downloads##

Опубліковано

2011-02-24

Номер

Розділ

Наукові огляди